Literature DB >> 12361412

Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision.

Marko B Lens1, Martin Dawes, Tim Goodacre, Julia A Newton Bishop.   

Abstract

BACKGROUND: The optimal excision margin for primary cutaneous melanoma remains controversial, although several clinical studies have suggested that wide local excision is unnecessary. HYPOTHESIS: Wide excision margins do not improve survival in patients with melanoma.
OBJECTIVES: To describe the published evidence and determine the effectiveness of wide surgical margins compared with narrow surgical margins.
DESIGN: Systematic review of randomized controlled trials that compared narrow margins with wide excision margins for cutaneous melanoma.
SETTING: Randomized controlled trials available by March 2001.
SUBJECTS: The included trials comprised 2406 participants. INTERVENTION: Surgical excision of melanoma using narrow excision margins compared with excision using wide excision margins. MAIN OUTCOME MEASURE: Effect of width of excision margin on melanoma recurrences, disease-free survival, and overall survival.
RESULTS: We identified and analyzed 4 randomized controlled trials. All 4 trials failed to demonstrate statistically significant differences in overall survival and disease-free survival when comparing wide vs narrow excision. Peto pooled odds ratio for overall survival was 0.79 (95% confidence interval, 0.61-1.04) and for disease-free survival was 0.89 (95% confidence interval, 0.69-1.13), indicating a statistically nonsignificant improvement with wide excision.
CONCLUSIONS: Not one of the included studies showed any statistically significant difference between the 2 groups treated with narrow or wide excision margins with regard to recurrences and survival. However, current evidence is not sufficient to address the optimal surgical margins for all melanomas, and further research is required.

Entities:  

Mesh:

Year:  2002        PMID: 12361412     DOI: 10.1001/archsurg.137.10.1101

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  13 in total

1.  Mayo Clinic consensus recommendations for the depth of excision in primary cutaneous melanoma.

Authors:  Travis E Grotz; Svetomir N Markovic; Lori A Erickson; William S Harmsen; Marianne Huebner; David R Farley; Barbara A Pockaj; John H Donohue; Franklin H Sim; Clive S Grant; Sanjay P Bagaria; Thomas C Shives; Charles M Balch; James W Jakub
Journal:  Mayo Clin Proc       Date:  2011-06       Impact factor: 7.616

2.  Management of regional lymph node basins in melanoma.

Authors:  Timothy P Love; Keith A Delman
Journal:  Ochsner J       Date:  2010

3.  Adjuvant Immunotherapy and Radiation in the Management of High-risk Resected Melanoma.

Authors:  Ricardo J Gonzalez; Ragini Kudchadkar; Nikhil G Rao; Vernon K Sondak
Journal:  Ochsner J       Date:  2010

Review 4.  Surgical Management of Melanoma: Advances and Updates.

Authors:  Juan A Santamaria-Barria; Joshua M V Mammen
Journal:  Curr Oncol Rep       Date:  2022-06-03       Impact factor: 5.075

5.  Is a Wider Margin (2 cm vs. 1 cm) for a 1.01-2.0 mm Melanoma Necessary?

Authors:  Matthew P Doepker; Zachary J Thompson; Kate J Fisher; Maki Yamamoto; Kevin W Nethers; Jennifer N Harb; Matthew A Applebaum; Ricardo J Gonzalez; Amod A Sarnaik; Jane L Messina; Vernon K Sondak; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2016-03-08       Impact factor: 5.344

Review 6.  Malignant melanoma (non-metastatic).

Authors:  Philip Savage
Journal:  BMJ Clin Evid       Date:  2007-06-01

7.  The biological effect and mechanism of the Wnt/β-catenin signaling pathway on malignant melanoma A375 cells.

Authors:  Yuxia Lin; Fangfei Wang; Qingfei Xing; Feng Guo; Mengzhen Wang; Yunjie Li
Journal:  Exp Ther Med       Date:  2018-07-06       Impact factor: 2.447

Review 8.  Surgery and radiotherapy in the treatment of cutaneous melanoma.

Authors:  A Testori; P Rutkowski; J Marsden; L Bastholt; V Chiarion-Sileni; A Hauschild; A M M Eggermont
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

9.  Head and neck melanoma.

Authors:  R Shashanka; B R Smitha
Journal:  ISRN Surg       Date:  2012-03-26

10.  TNF-alpha increases human melanoma cell invasion and migration in vitro: the role of proteolytic enzymes.

Authors:  E Katerinaki; G S Evans; P C Lorigan; S MacNeil
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.